Cardiocore Expertise
Whether undertaking Thorough QT studies, global late-phase ECG studies or ECHO/MUGA trials, sponsors benefit by receiving knowledgeable and accessible support from Cardiocore’s cardiac safety experts. When scientific advice is thoughtfully aligned with a sponsor’s programmatic goals, the collaboration helps ensure that the correct types and quantities of cardiac safety data are acquired and analyzed at the optimum moments within a drug’s development cycle.
Cardiocore’s industry-leading scientific team provides sponsor-benefiting expertise. The team comprises four cardiac safety thought leaders and two of the core lab industry’s founding fathers. Their comprehensive experience includes:
- Hundreds of clinical protocols
- Hundreds of pharmaceutical and biotech clients
- Experience in Phase I-IV clinical trials worldwide
- Design and implementation for Thorough QT studies
- Collaboration with regulatory agencies
- Superior ECG, Holter , ABPM, and ECHO/MUGA knowledge
Cardiocore’s scientific leaders are supported by a highly qualified team of statisticians, protocol analysts, board certified cardiologists and other medical doctors with extensive cardiovascular research expertise. This prominent team enables Cardiocore consultants to remain easily accessible to their pharmaceutical and biotech clients before and during each consulting engagement.
Cardiocore’s scientific consulting services for ECG, Holter, ABPM, and ECHO/MUGA include:
- Protocol Development
- Cardiac Safety Reports
- Statistical Analysis Plans and Reports
- Regulatory Guidance and Support
- Strategic Planning for Cardiac Safety Assessment
Many sponsors rely on Cardiocore’s scientific experts for protocol development services. In those engagements, key success factors include Cardiocore’s:
- Experts, who have comprehensive knowledge across all aspects of cardiology and therapeutic areas
- Experts, who have open accessibility and use a collaborative approach
- Long-lasting relationships with key regulators and industry experts
- Up-to-the-moment knowledge of regulatory trends regarding cardiac safety
- Highly experienced support team for protocol development
- Sponsor-focused, methodical approach to research, development and publishing protocol documents
Cardiocore’s experts also regularly provide cardiac safety seminars for pharmaceutical and biotech organizations. These seminars may cover broad aspects of cardiac testing strategy, or may be focused on a sponsor’s particular areas of interest, such as oncology or biologics. Click here to request a cardiac safety seminar for your organization.